血糖控制良好的2型糖尿病患者十年周围神经功能变化
本研究基于德国糖尿病研究队列,比较近期诊断且控制良好的2型糖尿病患者与糖耐量正常者在5年和10年间的下肢周围神经功能变化。结果显示两组5年下降程度相似,糖尿病组10年异常神经传导速度患病率与自然衰老预期估计接近,提示神经功能恶化主要与诊断时状态及生理衰老相关,而非糖尿病相关进展。
要点
- 控制良好的2型糖尿病神经功能下降与正常糖耐量者相似
- 诊断时神经功能状态和生理衰老是神经功能恶化的主要影响因素
- 10年异常神经传导速度患病率与自然衰老预期估计接近
核心结论
- 控制良好的2型糖尿病神经功能恶化主要受诊断时神经功能状态和生理衰老影响,而非糖尿病相关进展。
研究设计与样本
- 前瞻性观察性研究,纳入德国糖尿病研究中近期诊断(≤1年)的2型糖尿病患者及年龄、性别匹配的糖耐量正常者。
- 5年分析包括52例糖尿病患者和52例匹配的糖耐量正常者,10年分析在更大糖尿病队列(141例)中进行。
- 神经功能参考测试包括腓总运动神经传导速度、腓肠感觉神经传导速度、腓肠感觉神经动作电位、踝部振动感知阈值和热检测阈值。
主要发现
- 基线时,糖尿病组全部5项神经功能指标均较匹配的糖耐量正常组受损。
- 5年后,糖尿病组有2项神经指标下降(腓总运动神经传导速度和振动感知阈值),糖耐量正常组有3项下降(腓总运动神经传导速度、振动感知阈值和冷热检测阈值)。
- 调整基线值和配对匹配后,两组5年下降程度相似。
- 糖耐量正常组的神经病变残疾评分增加,而糖尿病组未增加。
- 在141例糖尿病队列中,5年和10年后的下降模式相似。
临床怎么用
- 对控制良好的近期诊断2型糖尿病患者,应关注诊断时已存在的神经功能状态。
- 神经功能随访变化可参考生理衰老预期,避免过度归因于糖尿病进展。
局限性
- 5年比较样本量较小(各52例)。
- 10年分析仅在糖尿病队列中进行,缺乏匹配的糖耐量正常组长期对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: There is a lack of knowledge on the changes in peripheral nerve function in people with well-controlled, recently diagnosed type 2 diabetes compared with those with normal glucose tolerance (NGT). In this study, we aimed to investigate the natural course of the function of lower extremity small and large nerve fibers in people with NGT and its decline in those with well-controlled type 2 diabetes. METHODS: This prospective observational study assessed changes in nerve function in participants of the German Diabetes Study with recently diagnosed (≤1 year) type 2 diabetes and age-matched and sex-matched individuals with NGT after 5 years and in a larger group of participants with type 2 diabetes after 5 and 10 years. Reference tests of lower extremity peripheral nerve function included peroneal motor nerve conduction velocity (MNCV) and sural sensory nerve conduction velocity (SNCV), sural sensory nerve action potential (SNAP), malleolar vibration perception threshold (VPT), and thermal detection thresholds (TDTs). Data were analyzed using multiple linear or logistic regression analyses. RESULTS: At baseline, all 5 nerve function measures showed impairment in the 52 individuals in the diabetes group (33% female, median age 51.7 years) compared with the 52 individuals in the matched NGT group (33% female, median age 51.4 years). After 5 years, 2 nerve indices declined in the diabetes group (peroneal MNCV and VPT) and 3 in the NGT group (peroneal MNCV, VPT, and TDT for cold), with similar 5-year declines observed in both groups after adjustment for baseline values and pairwise matching. In addition, the Neuropathy Disability Score increased in the NGT group but not in the diabetes group. Comparable patterns of decline after 5 and 10 years were found in the larger diabetes cohort of 141 individuals (39% female, median baseline age 53.6 years). The observed 10-year prevalence of abnormal NCVs closely matched estimates based on natural aging-related decline (14.2% vs 12.8% for peroneal MNCV and 30.2% vs 31.0% for sural SNCV). DISCUSSION: These findings suggest that nerve function deterioration in well-controlled type 2 diabetes is primarily influenced by nerve function status at diagnosis and physiologic aging, rather than diabetes-related progression.
引用
- Strom A, Strassburger K, Ziegler D, et al. Changes Over 10 Years in Peripheral Nerve Function in People With Well-Controlled Type 2 Diabetes and Those With Normal Glucose Tolerance. Neurology. 2025. PMID: 40440593. doi:10.1212/WNL.0000000000213780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。